The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid
Dörr, U.; Sautter-Bihl, M.L.; Bihl, H.
Seminars in Oncology 21(5 Suppl 13: 42-45
1994
ISSN/ISBN: 0093-7754 PMID: 7992080 Document Number: 430929
Document emailed within 1 workday
Related Documents
Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559Görges, R.; Kahaly, G.; Müller-Brand, J.; Mäcke, H.; Walgenbach, S.; Bruns, C.; Andreas, J.; Brandt-Mainz, K.; Bockisch, A. 1999: Somatostatin receptor status in non-medullary thyroid carcinoma Nuklearmedizin. Nuclear Medicine 38(1): 15-23
Biterman, A.; Bloch, B.; Wolf, T.; Baron, E.; Lephel, O.; Cohen, O. 2002: Difficulties in diagnosis and localization of recurrent medullary thyroid carcinoma Harefuah 141(2): 145-147; 223
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741
Miyauchi, A.; Matsuzaka, F.; Kuma, K.; Endo, K.; Ogihara, T.; Maeda, M. 1987: Diagnosis of adrenal medullary diseases in patients with sporadic or hereditary medullary thyroid carcinoma. A report of 37 cases with 8-year follow-up study Nihon Geka Gakkai Zasshi 88(10): 1423-1429
Koc, E.U.; Ozgur, T.; Yerci, O.; Gurel, S. 2013: Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma Hepato-Gastroenterology 60(127): 1693-1697
Ravitch, M.M. 1974: Diagnosis and prognosis of medullary carcinoma of the thyroid Medical Times 102(7): 131-132
Miyauchi, A.; Takai, S. 1978: Diagnosis and early detection of medullary carcinoma of the thyroid Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1564-1565
Myoteri, D.; Dellaportas, D.; Carvounis, E.; Kondi-Pafiti, A.; Vassiliou, I. 2016: Mixed medullary and papillary thyroid carcinoma: a stepwise diagnosis Journal of Buon: Official Journal of the Balkan Union of Oncology 21(6): 1561-1562
Rufini, V.; Salvatori, M.; Garganese, M.C.; Di Giuda, D.; Lodovica Maussier, M.; Troncone, L. 2000: Role of nuclear medicine in the diagnosis and therapy of medullary thyroid carcinoma Rays 25(2): 273-282
Fontanini, G.; Vignati, S.; Pacini, F.; Pollina, L.; Basolo, F. 1996: Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(6): 636-641
Nagaoka, H.; Iino, Y.; Takei, H.; Maemura, M.; Horiguchi, J.; Horii, Y.; Matumoto, H.; Koibuchi, Y.; Ninomiya, J.; Yokoe, T.; Oyama, T.; Morishita, Y. 1998: Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25 Suppl. 3: 481-485
Meyer, P.; Bohnen, N.I.; Barkan, A.L.; Shapiro, B. 1999: Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma Nuklearmedizin. Nuclear Medicine 38(2): 66-67
Limouris, G.S.; Rassidakis, A.; Kondi-Paphiti, A.; Triantafyllou, N.; Manetou, A.; Giannakopoulos, V.; Toubanakis, N.; Psyhojios, I.; Stavraka, A.; Vlahos, L. 1997: Somatostatin receptor scintigraphy of non-neuroendocrine malignancies with 111In-pentetreotide Anticancer Research 17(3b): 1593-1597
Kisker, O.; Bartsch, D.; Weinel, R.J.; Joseph, K.; Welcke, U.H.; Zaraca, F.; Rothmund, M. 1997: The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors Journal of the American College of Surgeons 184(5): 487-492
Zhao, J.-q.; Guo, L.; Qi, X.-p.; Chen, Z.-g.; Wang, K.-j.; Lou, J.-l.; Yu, X.-h.; Cheng, J.; Jin, H.-y.; Li, X.-l.; Ying, R.-b.; Zhang, X.-n. 2013: Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree Zhonghua Yi Xue Za Zhi 93(6): 440-444
Kakudo, K.; Vacca, L.L. 1983: Immunohistochemical study of substance P-like immunoreactivity in human thyroid and medullary carcinoma of the thyroid Journal of Submicroscopic Cytology 15(2): 563-568
Roos, B.A.; Deftos, L.J.; Roberts, G.; Wilson, P.; Bundy, L. 1976: Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat Journal of Laboratory and Clinical Medicine 88(2): 173-182
Kälkner, K.M.; Janson, E.T.; Nilsson, S.; Carlsson, S.; Oberg, K.; Westlin, J.E. 1995: Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers Cancer Research 55(23 Suppl): 5801s-5804s
Høie, J.; Jørgensen, O.G.; Karlsen, K.O.; Winther, F.O. 1990: Thyroid carcinoma and the recurrent nerve. Recurrence fall-out, incidence and causal circumstances in a large case-load of patients with thyroid carcinoma Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(8): 953-955